Stock Taper
CCM
CONCORD MEDICAL SERVICES HOLDINGS LIMITED
NYSE
$4.76
▼ DOWN 2.86% (-0.14)

KEY STATISTICS

Market Cap$693.12 K
52w High$6.98
52w Low$3.18
Dividend Yield2.02%
FrequencySpecial
P/E-0.32
Volume37.22K
Shares Out.145.61K

COMPANY

LEADERSHIP

Jianyu Yang
CHIEF EXECUTIVE
Jianyu Yang

ABOUT

SECTOR
Healthcare
WENT PUBLIC
December 11, 2009
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
610

UPCOMING EARNINGS

DateSep 25, 2026
DayFriday
Rev. Est.
SEP
25
FRI

SPLIT RECORD

DATETYPERATIO
2024-07-30Reverse1:10
2014-01-16Forward1423:1250

PRICE

$4.76 ▼ DOWN 2.86% (−$0.14)
OVERLAYS
$4.65$4.80$4.959:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM4.76

About Concord Medical Services Holdings Limited

https://www.concordmedical.com ↗

Concord Medical Services Holdings Limited operates radiotherapy, diagnostic imaging, and cancer treatment centers across China, providing advanced medical services, equipment leasing, clinical support, and hospital management through its network o...

INDUSTRY

Medical - Care Facilities

A SERVICE CONCORD MEDICAL SERVICES HOLDINGS LIMITED IS KNOWN FOR

Proton Therapy Services

Concord Medical's Proton Therapy provides advanced, precise cancer radiation treatment at specialized centers like Guangzhou Concord Cancer Center, offering potentially fewer side effects through targeted tumor therapy.

COMPETITORS

Revenue by Products

IconPRODUCTFY2022FY2023FY2024FY2025
Services and other revenues$518.5M $500.07M $372.06M $374.63M
Medicine income$87.09M $100.46M $83.02M $79.7M
Equipment Leasing Revenues$21.97M $16.74M $9.36M $8.49M

Revenue by Geography

MapREGIONFY2019FY2020FY2021FY2022
CHINA$485.63M $472.08M
C$164.17M $199.37M
S$34.2M $23.64M

INSTITUTIONAL OWNERSHIP

SHARES OWNED
87.18%
HOLDERS
4
TOP 4 OF 4 · RANKED BY POSITION SIZE
Greenwoods Asset Management Ltd
113.5K sh · $311K
Virtu Kcg Holdings LLC
11.0K sh · $41K
Ubs AG
1.9K sh · $13K
Eversource Wealth Advisors, LLC
440 sh · $2.7K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity3
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

OFFICER: INTERIM CFO
Shi Botao
· —
2026-06-30
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Yang Jianyu
· —
2026-03-18
DIRECTOR:
Yu Wayne (NMN)
· —
2026-03-18
OFFICER
Jiang Wei (NMN)
· —
2026-03-18

SECTORS PEERS

PEERPRICE
CELU$1.58COMPARE
SYRA$0.80COMPARE
ADTX$0.01COMPARE
IVF$1.00COMPARE
HEPA$0.10COMPARE
XAGE$0.22COMPARE
PTPI$0.00COMPARE
BACK$0.00COMPARE